Cormedix Inc (HAM:19KA)
€ 6.5 -0.60 (-8.47%) Market Cap: 542.06 Mil Enterprise Value: 512.84 Mil PE Ratio: 3.69 PB Ratio: 1.41 GF Score: 39/100

CorMedix Inc Annual Shareholders Meeting Transcript

Jun 23, 2026 / 01:00PM GMT
Release Date Price: €7.41 (+2.43%)
Susan Blum
CorMedix Inc - Chief Financial Officer, Executive Vice President

It's a pleasure to welcome you to our 2026 Annual Meeting of Stockholders. Today's meeting is being held virtually, as this allows us to reach a greater number of our stockholders. This meeting is now called to order.

Before we begin, I would like to introduce the Company's Officers who are with us today, including Joe Todisco, CorMedix Chairman and Chief Executive Officer; Liz Hurlburt, CorMedix EVP and Chief Operating Officer; Beth Zelnick-Kaufman; CorMedix EVP and Chief Legal and Compliance Officer and Corporate Secretary; Mike Seckler, CorMedix EVP and Chief Commercial Officer; and Dr. Matt David, CorMedix EVP and Chief Business Officer.

I would also like to extend a welcome to our Board Members who are joining us today.

I would now like to turn the meeting over to Beth Zelnick-Kaufman, to handle procedural matters.

Beth Kaufman
CorMedix Inc - Executive Vice President, Chief Legal Officer and Corporate Secretary

Thank you, Susan. I've been appointed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot